Detection of antimicrobial resistance by small rural hospital microbiology laboratories: comparison of survey responses with current NCCLS laboratory standards.

[1]  C. Whitney,et al.  Assessment of susceptibility testing practices for Streptococcus pneumoniae--United States, February 2000. , 2002, MMWR. Morbidity and mortality weekly report.

[2]  R. Jones,et al.  Method preferences and test accuracy of antimicrobial susceptibility testing: updates from the College of Amercian Pathologists Microbiology Surveys Program. , 2001, Archives of pathology & laboratory medicine.

[3]  F. Tenover,et al.  Development and spread of bacterial resistance to antimicrobial agents: an overview. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  J. Boyce.  Consequences of inaction: importance of infection control practices. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  R. Gaynes,et al.  Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  Victor L. Yu,et al.  Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology Laboratory , 2001, Journal of Clinical Microbiology.

[7]  E J Baron,et al.  Role of clinical microbiology laboratories in the management and control of infectious diseases and the delivery of health care. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  F. Tenover,et al.  Ability of Laboratories To Detect Emerging Antimicrobial Resistance: Proficiency Testing and Quality Control Results from the World Health Organization's External Quality Assurance System for Antimicrobial Susceptibility Testing , 2001, Journal of Clinical Microbiology.

[9]  T. Ricketts,et al.  Hospitals in rural America. , 2000, The Western journal of medicine.

[10]  R. Gaynes,et al.  Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories. , 2000, Diagnostic microbiology and infectious disease.

[11]  R. Gaynes,et al.  Practices to Improve Antimicrobial Use at 47 US Hospitals the Status of the 1997 SHEA/IDSA Position Paper Recommendations , 2000, Infection Control & Hospital Epidemiology.

[12]  F. Tenover,et al.  Detection and Reporting of Organisms Producing Extended-Spectrum β-Lactamases: Survey of Laboratories in Connecticut , 1999, Journal of Clinical Microbiology.

[13]  R. Gaynes,et al.  Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  M. Pfaller,et al.  Assessment of laboratory performance with Streptococcus pneumoniae antimicrobial susceptibility testing in the United States: a report from the College of American Pathologists Microbiology Proficiency Survey Program. , 1999, Archives of pathology & laboratory medicine.

[15]  B. Robinson-Dunn,et al.  Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. , 1999, The New England journal of medicine.

[16]  F. Tenover,et al.  Characterization of Staphylococci with Reduced Susceptibilities to Vancomycin and Other Glycopeptides , 1998, Journal of Clinical Microbiology.

[17]  G. Stefánsdóttir,et al.  Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study , 1996, BMJ.

[18]  E. Petersen.  Emerging infectious disease. , 1996, Archives of Internal Medicine.

[19]  R A Weinstein,et al.  Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership. , 1996, JAMA.

[20]  F. Tenover,et al.  Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci , 1995, Journal of clinical microbiology.

[21]  J. Mcgowan,et al.  Do Intensive Hospital Antibiotic Control Programs Prevent the Spread of Antibiotic Resistance? , 1994, Infection Control & Hospital Epidemiology.

[22]  L. Peterson,et al.  Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital , 1991, Antimicrobial Agents and Chemotherapy.

[23]  W. Scheckler,et al.  Nosocomial Infections in 15 Rural Wisconsin Hospitals—Results and Conclusions from 6 Months of Comprehensive Surveillance , 1986, Infection Control.

[24]  W. Scheckler,et al.  Nosocomial Infection Prevalence, Risk and Control in Small Community and Rural Hospitals , 1986, Infection Control & Hospital Epidemiology.

[25]  R. Haley,et al.  The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. , 1985, American journal of epidemiology.

[26]  J. Mcgowan,et al.  Antimicrobial resistance in hospital organisms and its relation to antibiotic use. , 1983, Reviews of infectious diseases.

[27]  W. Schaffner,et al.  A Statewide Characterization of Hospital Infection Control Practices and Practitioners , 1980, Infection Control.

[28]  M. Britt.  Infectious diseases in small hospitals. Prevalence of infections and adequacy of microbiology services. , 1978, Annals of internal medicine.

[29]  C. B. Smith,et al.  Infection control in small hospitals. Prevalence surveys in 18 institutions. , 1976, JAMA.

[30]  Robert E. Johnson,et al.  From the Centers for Disease Control. Staphylococcus aureus resistant to vancomycin--United States, 2002. , 2002, JAMA.

[31]  W. R. Jarvis,et al.  Building communication networks: international network for the study and prevention of emerging antimicrobial resistance. , 2001, Emerging infectious diseases.

[32]  R. Weinstein,et al.  Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  D. Goldmann,et al.  Control of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  K. Kristinsson,et al.  Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. , 1997, Microbial drug resistance.

[35]  D. Gerding,et al.  Infection Control and Hospital Epidemiology Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in Hospitals Shea Position Paper Infection Co , 2022 .